广发纳斯达克生物科技人民币(001092)
动态评分: 5.28分
投资组合

报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
2020-12-31 | FGEN | FibroGen Inc | 28.8 | 0.29% |
2020-12-31 | NKTR | 内克塔治疗 | 29.32 | 0.29% |
2020-12-31 | INSM | Insmed Inc | 27.89 | 0.28% |
2020-12-31 | DCPH | Deciphera Pharmaceuticals Inc | 28 | 0.28% |
2020-12-31 | ALKS | 阿尔凯默斯 | 27.47 | 0.27% |
2020-12-31 | ALLO | Allogene Therapeutics Inc | 27.35 | 0.27% |
2020-12-31 | NTLA | Intellia Therapeutics Inc | 27.19 | 0.27% |
2020-12-31 | RCKT | Rocket Pharmaceuticals Inc | 25.66 | 0.26% |
2020-12-31 | AXSM | Axsome Therapeutics Inc | 25.68 | 0.26% |
2020-12-31 | AGIO | Agios Pharmaceuticals Inc | 26.41 | 0.26% |
2020-12-31 | KRTX | Karuna Therapeutics Inc | 24.33 | 0.24% |
2020-12-31 | OPK | OPKO健康 | 22.7 | 0.23% |
2020-12-31 | GBT | 全球血液疗法 | 22.66 | 0.23% |
2020-12-31 | BLUE | 蓝鸟生物 | 23.41 | 0.23% |
2020-12-31 | VCYT | Veracyte Inc | 23.37 | 0.23% |
2020-12-31 | PCRX | Pacira BioSciences Inc | 22.06 | 0.22% |
2020-12-31 | XNCR | Xencor Inc | 20.98 | 0.21% |
2020-12-31 | NSTG | NanoString Technologies Inc | 21.34 | 0.21% |
2020-12-31 | ITCI | Intra-Cellular Therapies Inc | 20.4 | 0.2% |
2020-12-31 | GRFS | 基立福 | 19.3 | 0.19% |
公告&资料
